Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 16,266 shares at $235.19 ($3.8M) on 2024-06-25, disclosed to the SEC on 2024-06-26.
Open-market sale of $3.8M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $221.71 | 308 | $68K | 1.8% |
| 2 | $221.71 | 308 | $68K | 1.8% |
| 3 | $224.17 | 66 | $15K | 0.4% |
| 4 | $225.55 | 93 | $21K | 0.6% |
| 5 | $226.82 | 177 | $40K | 1.1% |
| 6 | $228.30 | 666 |
| $152K |
| 4.0% |
| 7 | $228.30 | 666 | $152K | 4.0% |
| 8 | $229.06 | 1,374 | $315K | 8.4% |
| 9 | $229.06 | 1,374 | $315K | 8.4% |
| 10 | $229.93 | 1,572 | $361K | 9.6% |
| 11 | $229.93 | 1,572 | $361K | 9.6% |
| 12 | $231.59 | 511 | $118K | 3.1% |
| 13 | $231.59 | 511 | $118K | 3.1% |
| 14 | $232.54 | 1,119 | $260K | 6.9% |
| 15 | $232.54 | 1,119 | $260K | 6.9% |
| 16 | $233.53 | 595 | $139K | 3.7% |
| 17 | $233.53 | 595 | $139K | 3.7% |
| 18 | $234.66 | 957 | $225K | 6.0% |
| 19 | $234.66 | 957 | $225K | 6.0% |
| 20 | $235.19 | 863 | $203K | 5.4% |
| 21 | $235.19 | 863 | $203K | 5.4% |
| Total | $231.10 avg | 16,266 | $3.8M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |